Cincinnati, OH, United States of America

Nira Ben-Jonathan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Nira Ben-Jonathan: Pioneering Advances in Cancer Treatment

Introduction

Nira Ben-Jonathan is a notable inventor based in Cincinnati, OH, who has made significant contributions to the field of pharmaceuticals. Her innovative work focuses on developing small molecule prolactin receptor inhibitors, which hold promise in treating various disorders, including breast and prostate cancer.

Latest Patents

Nira holds two patents that specifically address the use of small molecule inhibitors (SMIs) of the prolactin receptor. These patents encompass pharmaceutical compositions and treatment methods designed for patients suffering from disorders characterized by increased expression or activation of the prolactin receptor. Disorders treated with these inventions include breast cancer, prostate cancer, and nociceptive pain disorders such as migraine headaches. The efficacy of these SMIs opens new avenues for therapeutic interventions and enhances patient care.

Career Highlights

Throughout her career, Nira has been associated with prestigious institutions, including the University of Cincinnati and the University of Texas System. Her roles in these universities have allowed her to collaborate with other experts in her field and contribute to groundbreaking research that bridges the gap between science and practical applications.

Collaborations

In her innovative journey, Nira has worked alongside talented individuals like Eric R. Hugo and Edward J. Merino. Collaborating with such professionals has enriched her research, enabling significant advancements in the understanding and treatment of disorders related to the prolactin receptor.

Conclusion

Nira Ben-Jonathan's contributions to the field of pharmaceuticals exemplify the importance of innovation in medicine. With her patents targeting crucial health issues, she continues to impact the lives of many patients through her research and development efforts. Her work not only reflects her dedication but also underscores the potential of small molecule inhibitors in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…